USP22 and neoplasm: In addition to its cancer cell-intrinsic roles, USP22 has been recently discovered to suppress tumor immunosurveillance through potentiating Foxp3 + regulatory functions 31,41 as well as upregulating the expression of checkpoint receptors PD-L1 and CD73 42, 43.